share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股SEC公告 ·  05/22 13:49
Moomoo AI 已提取核心訊息
Vertex Pharmaceuticals Inc. Director, Bruce I. Sachs, is set to sell 7,073 shares of common stock on 05/22/2024, as per the latest filing. The shares, valued at approximately $3,168,704, were originally acquired on the same date through an option granted on 06/01/2016. The transaction will be conducted with cash as the nature of payment. No other sales of securities have been reported by Sachs in the past three months.
Vertex Pharmaceuticals Inc. Director, Bruce I. Sachs, is set to sell 7,073 shares of common stock on 05/22/2024, as per the latest filing. The shares, valued at approximately $3,168,704, were originally acquired on the same date through an option granted on 06/01/2016. The transaction will be conducted with cash as the nature of payment. No other sales of securities have been reported by Sachs in the past three months.
根據最新文件,Vertex Pharmicals Inc.董事布魯斯·薩克斯定於2024年5月22日出售7,073股普通股。這些股票價值約3,168,704美元,最初是通過2016年1月6日授予的期權於同日收購的。該交易將以現金作爲付款性質進行。在過去的三個月中,薩克斯沒有報告其他證券銷售情況。
根據最新文件,Vertex Pharmicals Inc.董事布魯斯·薩克斯定於2024年5月22日出售7,073股普通股。這些股票價值約3,168,704美元,最初是通過2016年1月6日授予的期權於同日收購的。該交易將以現金作爲付款性質進行。在過去的三個月中,薩克斯沒有報告其他證券銷售情況。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息